Deep Genomics
Chip Baird is Chief Financial Officer at 2Seventy Bio (Nasdaq: TSVT), a commercial stage oncology cell therapy company. Prior to 2Seventy, Chip previously served as CFO for Bluebird Bio, Amicus Therapeutics, and PTC Therapeutics. Chip has more than 20 years of experience leading innovative biotech companies and also serves as a Director of Axcella Health.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Deep Genomics
4 followers
Revolutions in AI, biology and automation are enabling a new approach to medicine. Deep Genomics is at the forefront.